Education
About Us
Working with TipRanks
Follow Us
Windtree Therapeutics (WINT)
OTHER OTC:WINT
WINT Stock Chart & Stats
$0.13
-$0.02(-5.33%)
At close: 4:00 PM EST
$0.13
-$0.02(-5.33%)
Day’s Range― - ―
52-Week Range$0.06 - $60.00
Previous CloseN/A
Volume14.98M
Average Volume (3M)414.73K
Market Cap
$3.81M
Enterprise Value$14.15M
Total Cash (Recent Filing)$301.00K
Total Debt (Recent Filing)$8.69M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Nov 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.06
Shares Outstanding29,334,220
10 Day Avg. Volume502,500
30 Day Avg. Volume414,727
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap3.71
Enterprise Value/Revenue157.25
Enterprise Value/Gross Profit-122.00
Enterprise Value/Ebitda-0.97
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Windtree Therapeutics News
WINT FAQ
What was Windtree Therapeutics’s price range in the past 12 months?
Windtree Therapeutics lowest stock price was $0.06 and its highest was $60.00 in the past 12 months.
What is Windtree Therapeutics’s market cap?
Windtree Therapeutics’s market cap is $3.81M.
When is Windtree Therapeutics’s upcoming earnings report date?
Windtree Therapeutics’s upcoming earnings report date is Nov 06, 2025 which is in 19 days.
How were Windtree Therapeutics’s earnings last quarter?
Windtree Therapeutics released its earnings results on Aug 06, 2025. The company reported -$3.059 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.059.
Is Windtree Therapeutics overvalued?
According to Wall Street analysts Windtree Therapeutics’s price is currently Overvalued.
Does Windtree Therapeutics pay dividends?
Windtree Therapeutics does not currently pay dividends.
What is Windtree Therapeutics’s EPS estimate?
Windtree Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Windtree Therapeutics have?
Windtree Therapeutics has 29,334,220 shares outstanding.
What happened to Windtree Therapeutics’s price movement after its last earnings report?
Windtree Therapeutics reported an EPS of -$3.059 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.66%.
Which hedge fund is a major shareholder of Windtree Therapeutics?
Among the largest hedge funds holding Windtree Therapeutics’s share is Deerfield Management Company, LP. It holds Windtree Therapeutics’s shares valued at 0.
Windtree Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Hedge Fund Trend
Decreased
By 676.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 1.0%
Last 30 Days ▲ 4.6%
Last 30 Days ▲ 4.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.62%
12-Months-Change
Fundamentals
Return on Equity
-169.59%
Trailing 12-Months
Asset Growth
10.86%
Trailing 12-Months
Company Description
Windtree Therapeutics
Windtree Therapeutics, Inc. (WINT) is a biotechnology company focused on developing novel therapeutics for patients suffering from acute pulmonary disorders. The company primarily operates within the biopharmaceutical and healthcare sectors. Windtree's lead product candidates are designed to address significant unmet medical needs in areas such as respiratory distress syndrome (RDS) in premature infants and acute respiratory failure in adults. The company leverages its proprietary KL4 surfactant technology and other innovative therapeutic approaches to enhance patient outcomes.
Technical Analysis
Theriva Biologics
―
Alaunos Therapeutics
―
Sonnet BioTherapeutics Holdings
―
Oragenics
―
Xenetic Biosciences
―
Ownership Overview
0.03% Insiders
0.03% Mutual Funds
<0.01% Other Institutional Investors
99.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---